Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV001280044 | SCV002780657 | uncertain significance | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003481048 | SCV004226937 | uncertain significance | not provided | 2022-09-30 | criteria provided, single submitter | clinical testing | PM2 |
Natera, |
RCV001280044 | SCV001467191 | uncertain significance | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 | 2020-08-14 | no assertion criteria provided | clinical testing |